Global Hematology Analyzers and Reagents Market Size by Products & Services [Hematology Analyzers (5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology], Price Range (High, Low), Application (Anemia, Blood Cancer, Hemorrhagic Conditions, Infection-Related Conditions, Immune System Related Conditions, Others), End-User (Hospital Laboratories, Blood Banks, Commercial Service Providers, Government Reference Laboratories, Research & Academic Institute, Others), By Region (North America, Europe, Asia Pacific, South America, and the Middle East & Africa), (Trend Analysis, Market Competition Scenario & Outlook, 2016-2026.

Published:
September 2020
Report Code:
bwc20165
Available Format:
PDF PDF Icon
Pages:
180

global hematology analyzers and reagents market bwc20165

Global Hematology Analyzers and Reagents Market Size - Industry Trends & Outlook Report 2026

 

Global Hematology Analyzers and Reagents Market is estimated to be USD 5.14 billion by 2026 from USD 3.2 billion in 2019, at a CAGR of 7% from 2020 to 2026. The rising volume of blood donation combined with the high occurrence of blood syndromes is acting as major drivers for the market. Improvements and advancements in technology, such as hematology analyzers with flow cytometry instrumentations, are increasing the demands prospective for growth. Growing emphasis of market players on the evolution of high throughout examining instruments and the focus on emerging highly profound point-of-care test instruments and products are also acting as significant development drivers for the hematology analyzers and reagents market.

 

Lack of fondness, resulting in the slow acceptance rate of this instrumentation from the world's emerging regions, is acting as restrictors for market growth. Increasing concerns amongst consumers regarding these devices' safety and efficiency amid fresh product recalls by the significant market players.

 

Global Hematology Analyzers and Reagents Market: Market Outlook and Trends

 

Hematology analyzers and reagents are the healthcare products and consumables planned to recognize and count the individual blood cells in an extremely efficient and high-speed method. These instruments have substituted the old-style methods of counting blood cells separately under a microscope that was carried out formerly by the lab technicians. These devices provide more accurate and well-organized results concerning blood cells and other linked information from the blood sample.

 

Global Hematology Analyzers and Reagents Market

 

Growth Drivers

 

Increased screening of blood 

The growth of this market is mainly due to the increased screening of blood in the pandemic. Hematology Analyzers are used for white blood cell counts, complete blood counts, reticulocyte analysis, and coagulation tests in the patients suffering from coronavirus. Rapid growth in the number of COVID 19 patients is thus driving the hematology analyzers and reagents market.

 

Rising number of blood donations

The increasing number of blood donations worldwide motivates the hematology analyzers and reagents market as hematology analyzers are used to check and monitor blood in blood banks. Blood collected from donors through blood donation booths or bloodmobiles is sent to blood banks where hematology analyzers monitor and test the blood. These screening tests regulate the blood type, examine the blood plasma, and identify contagious diseases. Blood banks are witnessing massive blood drainage to hospitals and other end-users and inflow of blood from blood aids daily.

 

Restraint

 

High costs related to procurement and application are the main factor of the global hematology analyzers and reagents market. Additionally, difficulties rising from reuse and limited acceptance of hematology analyzers and reagents hinder the global hematology analyzers' growth and reagents market over the forecast period.

 

Impact of COVID-19 in industry

 

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so and, the long-term effects projected to impact the industry growth during the forecast period. 

 

Global Hematology Analyzers and Reagents Market: Segmentation

 

The hematology analyzers and reagents market are segmented into hemostasis, hematology, and immunohematology based on products & services. The hematology products & services section accounted for the largest market share in 2019. This can be credited to the rising acceptance of POC testing hematology analyzers in emerging economies, the introduction of technologically advanced hematology products, the increasing fondness of automation, and the accessibility of a wide range of services leading hematology providers.

 

By price range, the hematology instruments market is classified into high-end, mid-range, and low-end hematology analyzers. The low-end hematology analyzers segment accounted for the largest share of the global hematology instruments market in 2019.

 

The hematology analyzers and reagents market has been segmented based on application into anemia, blood cancer, hemorrhagic conditions, infection-related conditions, immune-system related conditions, and others.

 

Based on end-users, the hematology products & services market is segmented into hospital laboratories, commercial service providers, government reference laboratories, and research & academic institutes. In 2019, the commercial service providers segment accounted for the largest share of the market owing to the increasing incidence of leukemia and anemia, shift from manual testing to automated testing, and the competitive benefits offered by these providers as compared to hospitals (such as affordable service costs, efficient turnaround time, and efficient management for sample collection).

 

Global Hematology Analyzers and Reagents Market: Regional Insights

 

The market in North America accounts for a significant share in the global hematology analyzers and reagents market in income terms, owing to rising mindfulness about blood-related infections and cures and proper medical infrastructure in the region. Europe's market accounted for the second-highest revenue share in the global hematology analyzers and reagents market, owing to high healthcare expenditure by governments of countries, and high disposable income, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa, respectively.

 

Competitive landscape

 

The leading players in the Hematology Analyzers and Reagents Market include Sysmex Corporation (Japan), Danaher Corporation (US), Nihon Kohden (Japan), Siemens (Germany), Abbott (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland) and other prominent players.

 

Recent Developments

·         October 2020, Nihon Kohden Launches NK-HealthProtect™ to Help Health Professionals during COVID-19 in the U.S.

·         In July 2017, Sysmex launched the XN-L automated hematology analyzers in the US.

·         In May 2016, Sysmex Asia Pacific (Singapore) opened a branch in Yangon, Myanmar, to enhance after-sales support and customer services in Myanmar.

 

Scope of the Report

 

Attribute

Details

Years Considered

Historical data – 2016-2018

Base Year – 2019

Forecast – 2020 – 2026

Facts Covered

Revenue in USD Billion

Market Coverage

U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, UAE, South Africa, Saudi Arabia .

Product/Service Segmentation

By Product & Services, By Price Range, By Application, By End User, By Region

Key Players

The leading players considered for market analysis are Sysmex Corporation (Japan), Danaher Corporation (US), Nihon Kohden (Japan), Siemens (Germany), Abbott (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland) and many others.

 

 

·         By Product & Services

ü  Hematology Analyzers

o    5 Parts

o    6 Parts

o    3 Part

o    PoC

o    Semi-Automated

ü  Hemostasis

ü  Immunohematology

·         By Price Range

ü  High

ü  Low

·         By Application

ü  Anemia

ü  Blood Cancer

ü  Hemorrhagic Conditions

ü  Infection-Related Conditions

ü  Immune System Related Conditions

ü  Others

·         By End User

ü  Hospital Laboratories

ü  Blood Banks

ü  Commercial Service Providers

ü  Government Reference Laboratories

ü  Research & Academic Institute

ü  Others

·         By Region

ü  North America

ü  Europe

ü  Asia Pacific

ü  South America

ü  Middle East & Africa

 

The objective of the Study:

•To analyze and forecast the Global Hematology Analyzers and Reagents Market size of the market in terms of value.

•To examine the careful market segmentation and forecast the market size, in terms of value, based on the region by segmenting.

•The Global Hematology Analyzers and Reagents Market segmented into five regions, namely, North America, Europe, Asia Pacific, Middle East, South America, and their leading countries.

•To outline, categorized, and forecast the Global Hematology Analyzers and Reagents Market based on By Product & Services, By Price Range, By Application, By End User and by Regional

•To examine competitive developments like By Product & Services, By Price Range, By Application, By End User and by Regional within the Global Hematology Analyzers and Reagents Market.

•To highlight the impact analysis of the factors affecting the market dynamics such as growth drivers.

•To strategically profile the key players and comprehensively analyze their market shares along with detailing the competitive landscape for market leaders.

 

Business Questions Answer by the Report

         How will the market drivers, restraints, and opportunities affect the market dynamics?

         What will be the market size in terms of value and volume and market statistics with a detailed classification?

         Which segment dominates the market or region, and one will be the fastest - growing, and why?

         A comprehensive survey of the competitive landscape and the market participant players

         Analysis of strategy adopted by the key player and their impact on other players.

Customization Scope for the Client

Client satisfaction is our first and last priority, and that is why BlueWeave Consulting offers customization according to Company’s specific needs. The following customization options are available for the report:

Additional Company Information

•    With five additional company detail analysis

•    Additional country analysis

•    Detailed segment analysis

COVID-19

We've been tracking the direct impact of COVID-19 on this market, and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Contact our sales team for more details at

Contact Now

WHY CHOOSE US

  • 24/7 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Coustom Research Service

    Ask the Analyst to customize an exclusive study to serve your research needs.

  • Quality & Accuracy

    offers best quality reports based on various authentic and accurate data findings.

  • Data Visualization

    As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization

  • Information security

    We never share your personal and confidential information. Your personal information is safe and secure with us.